A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer

Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound

10 p | 7 | 3

A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer

10 p | 6 | 3

Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide

9 p | 11 | 2

Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma

7 p | 8 | 2

BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: A first-inhuman phase-I study

8 p | 9 | 2

Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: A randomized controlled trial

9 p | 13 | 2

A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies

10 p | 8 | 2

Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: A prospective phase I subanalysis

10 p | 14 | 1

Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: Study protocol

7 p | 10 | 1